Clinical Trial Update: GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating GTI-2040 in combination with oxaliplatin and capecitabine for locally advanced or metastatic colorectal cancer and other solid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• GTI-2040 (GTI-2040)
• Xeloda (capecitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Status: COMPLETED